Drug Shortage Report for PRISM0CAL

Last updated on 2022-01-13 History
Report ID 139241
Drug Identification Number 02274876
Brand name PRISM0CAL
Common or Proper name PRISM0CAL
Company Name BAXTER CORPORATION
Market Status MARKETED
Active Ingredient(s) SODIUM BICARBONATE LACTIC ACID SODIUM CHLORIDE MAGNESIUM CHLORIDE
Strength(s) 58.8G 0.284G 6.449G 0.108G
Dosage form(s) SOLUTION
Route of administration DIALYSIS INTRAVENOUS DIALYSIS INTRAVENOUS
Packaging size 5L Bags (Product Code 113884)
ATC code B05ZA
ATC description HEMODIALYTICS AND HEMOFILTRATES
Reason for shortage Demand increase for the drug.
Anticipated start date 2021-06-06
Actual start date 2021-06-06
Estimated end date 2022-06-30
Actual end date
Shortage status Actual shortage
Updated date 2022-01-13
Company comments PrismaSOL 0 (113881)/ PrismaSOL 4 (113883)/ Prism0CAL (113884) / Prism0CAL B22 (115295) CRRT Solution is currently on 75% allocation, which means that 75% of a customer’s historic monthly demand would be automatically fulfilled. Any orders above this amount would require a customer to request an additional release through our customer care team for consideration. Demand for this product remains high, thus posing a risk for intermittent branch-level and/or national back orders over the next 2-4 months.
Health Canada comments
Tier 3 Status Yes
Contact Address 7125 MISSISSAUGA ROAD
MISSISSAUGA, ONTARIO
CANADA L5N 0C2
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2022-01-13 English Compare
v5 2021-12-14 French Compare
v4 2021-12-14 English Compare
v3 2021-06-07 English Compare
v2 2021-05-12 French Compare
v1 2021-05-12 English Compare

Showing 1 to 6 of 6